Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online before print September 5, 2007, doi:10.1212/01.wnl.0000278115.50741.4e)
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
01.wnl.0000278115.50741.4ev1
69/18/1737    most recent
Right arrow Correspondence:
Submit a response
Right arrow Correspondence:
View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nichols, W. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nichols, W. C.
Received December 15, 2006
Accepted February 28, 2007

LRRK2 mutation analysis in Parkinson disease families with evidence of linkage to PARK8

W. C. Nichols PhD*, V. E. Elsaesser BS, N. Pankratz PhD, M. W. Pauciulo MBA, D. K. Marek BS, C. A. Halter MS, A. Rudolph PhD, C. W. Shults MD, T. Foroud PhD, for the Parkinson Study Group– PROGENI Investigators

From Cincinnati Children’s Hospital Medical Center, Cincinnati, OH (W.C.N., V.E.E., M.W.P., D.K.M.); University of Cincinnati School of Medicine, Cincinnati, OH (W.C.N.); Indiana University Medical Center, Indianapolis, IN (N.P., C.A.H., T.F.); University of Rochester, Rochester, NY (A.R.); University of California, San Diego, La Jolla, CA (C.W.S.); and VA San Diego Healthcare System, San Diego, CA (C.W.S.).


* To whom correspondence should be addressed. E-mail: bill.nichols{at}cchmc.org.

ABSTRACT

Background: Pathogenic mutations in the leucine-rich repeat kinase 2 gene (LRRK2) have been found to cause typical, later-onset Parkinson disease (PD). Although G2019S is the most common mutation, other mutations have also been reported. It is critical to catalog the types of mutations found in LRRK2 that can cause PD, so as to provide insight regarding disease susceptibility and potential novel treatments.

Methods: We performed a comprehensive study of all 51 exons of the LRRK2 gene in one PD patient from each of 88 multiplex PD families who had the highest family-specific multipoint lod score at the LRRK2 locus from a cohort of 430 PD families without the G2019S mutation.

Results: Five families (5.7%) harbored what seem to be novel, pathogenic mutations (L1795F, I1192V, E10K, E334K, Q1111H). Three of these apparent mutations were in known, functional domains of the LRRK2 protein, where other studies have also identified disease producing mutations. However, two of the novel variants were found in the N-terminal region of LRRK2, where no pathogenic substitutions have yet been reported. Similar to previous studies, all subjects with an LRRK2 mutation had classic symptoms of PD and typical, later age at onset.

Conclusions: We have identified five novel variants in LRRK2, with two of these in the N-terminal region of LRRK2, where no pathogenic substitutions have been previously reported. If confirmed to be causative, these mutations would broaden the potential mechanisms whereby mutations in LRRK2 result in Parkinson disease.




This article has been cited by other articles:


Home page
NeurologyHome page
N. Pankratz, D. K. Kissell, M. W. Pauciulo, C. A. Halter, A. Rudolph, R. F. Pfeiffer, K. S. Marder, T. Foroud, W. C. Nichols, and For the Parkinson Study Group-PROGENI Investigator
Parkin dosage mutations have greater pathogenicity in familial PD than simple sequence mutations
Neurology, July 28, 2009; 73(4): 279 - 286.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
S Lesage, C Condroyer, A Lannuzel, E Lohmann, A Troiano, F Tison, P Damier, S Thobois, A-M Ouvrard-Hernandez, S Rivaud-Pechoux, et al.
Molecular analyses of the LRRK2 gene in European and North African autosomal dominant Parkinson's disease
J. Med. Genet., July 1, 2009; 46(7): 458 - 464.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
W. C. Nichols, D. K. Kissell, N. Pankratz, M. W. Pauciulo, V. E. Elsaesser, K. A. Clark, C. A. Halter, A. Rudolph, J. Wojcieszek, R. F. Pfeiffer, et al.
Variation in GIGYF2 is not associated with Parkinson disease
Neurology, June 2, 2009; 72(22): 1886 - 1892.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
S. Lesage and A. Brice
Parkinson's disease: from monogenic forms to genetic susceptibility factors
Hum. Mol. Genet., April 15, 2009; 18(R1): R48 - R59.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
W. C. Nichols, N. Pankratz, D. K. Marek, M. W. Pauciulo, V. E. Elsaesser, C. A. Halter, A. Rudolph, J. Wojcieszek, R. F. Pfeiffer, T. Foroud, et al.
Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset
Neurology, January 27, 2009; 72(4): 310 - 316.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
O. A. Ross, M. Toft, K. Haugarvoll, A. Chen-Plotkin, W. Yuan, C. Anderson, E. M. Wood, H.I. Hurtig, C. Clark, B.L. Miller, et al.
CORTICOBASAL SYNDROME AND PRIMARY PROGRESSIVE APHASIA AS MANIFESTATIONS OF LRRK2 GENE MUTATIONS
Neurology, July 22, 2008; 71(4): 303 - 304.
[Full Text] [PDF]


Home page
NeurologyHome page
V. Bonifati, Y-H Wu-Chou, D. Schweiger, A. D. Fonzo, C-S Lu, B. Oostra, W .C. Nichols, V .E. Elsaesser, N . Pankratz, M .W. Pauciulo, et al.
LRRK2 MUTATION ANALYSIS IN PARKINSON DISEASE FAMILIES WITH EVIDENCE OF LINKAGE TO PARK8
Neurology, June 10, 2008; 70(24): 2348 - 2349.
[Full Text] [PDF]

Correspondence:

Read all Correspondence

LRRK2 mutation analysis in Parkinson disease families with evidence of linkage to PARK8
Vincenzo Bonifati, et al.
Neurology Online, 27 Dec 2007 [Full text]
Reply from the authors
William C. Nichols, et al.
Neurology Online, 27 Dec 2007 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by AAN Enterprises, Inc.